These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16382454)

  • 1. The challenge of progressive hepatitis C following liver transplantation.
    Davis GL
    Liver Transpl; 2006 Jan; 12(1):19-21. PubMed ID: 16382454
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation.
    Firpi RJ; Zhu H; Morelli G; Abdelmalek MF; Soldevila-Pico C; Machicao VI; Cabrera R; Reed AI; Liu C; Nelson DR
    Liver Transpl; 2006 Jan; 12(1):51-7. PubMed ID: 16382464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative viral kinetics: new insights or the Emperor's new clothes?
    Charlton M
    Liver Transpl; 2006 Feb; 12(2):194-5. PubMed ID: 16447194
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcineurin inhibition and disease recurrence in the hepatitis C virus-positive liver transplant recipient.
    Pollard S
    Liver Int; 2004 Oct; 24(5):402-6. PubMed ID: 15482334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The challenge of preserving renal function after liver transplantation.
    Jacquet A; Francois H; Beaudreuil S; Hebibi H; Seidowsky A; Ahmad L; Charpentier B; Durrbach A
    Panminerva Med; 2009 Dec; 51(4):249-55. PubMed ID: 20195235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome.
    Watt KD; Lyden ER; Gulizia JM; McCashland TM
    Liver Transpl; 2006 Jan; 12(1):134-9. PubMed ID: 16382465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The common I148 M variant of PNPLA3 does not predict fibrosis progression after liver transplantation for hepatitis C.
    do O NT; Eurich D; Trautwein C; Neuhaus P; Neumann UP; Wasmuth HE
    Hepatology; 2011 Oct; 54(4):1483-4. PubMed ID: 21748761
    [No Abstract]   [Full Text] [Related]  

  • 8. Allograft TNFbeta and IL16 polymorphisms influence HCV recurrence and severity after liver transplantation.
    Kimball P; Baker M; Fisher RA
    Liver Transpl; 2006 Feb; 12(2):247-52. PubMed ID: 16447204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus recurrence after liver transplantation: influence of immunosuppressive regimens on viral load and liver histology.
    Oton E; Barcena R; Castillo M; Barreales M; Blesa C; Moreno-Planas JM; Barrios C; Garrido A; Cuervas V
    Transplant Proc; 2006 Oct; 38(8):2499-501. PubMed ID: 17097980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interrelation between recurrent hepatitis C, alloimmune response, and immunosuppression.
    Shaked A
    Liver Transpl; 2005 Nov; 11(11):1329-31. PubMed ID: 16237699
    [No Abstract]   [Full Text] [Related]  

  • 11. Preservation solutions in liver transplantation: what are the options?
    Eghtesad B; Aucejo F; Fung JJ
    Liver Transpl; 2006 Feb; 12(2):196-8. PubMed ID: 16447207
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetics of hepatitis C virus reinfection after liver transplantation.
    Powers KA; Ribeiro RM; Patel K; Pianko S; Nyberg L; Pockros P; Conrad AJ; McHutchison J; Perelson AS
    Liver Transpl; 2006 Feb; 12(2):207-16. PubMed ID: 16447184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapidly progressive recurrent hepatitis C virus infection starting 9 days after liver transplantation.
    Saraf N; Fiel MI; Deboccardo G; Emre S; Schiano TD
    Liver Transpl; 2007 Jun; 13(6):913-7. PubMed ID: 17539015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis C recurrence after liver transplantation].
    Guo F; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):382-4. PubMed ID: 15225448
    [No Abstract]   [Full Text] [Related]  

  • 15. Liver transplantation for liver disease caused by hepatitis C virus infection.
    Shankar A; Alexander G
    Br J Hosp Med (Lond); 2009 Feb; 70(2):95-100. PubMed ID: 19229150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and differentiation of rejection after liver transplantation: report of 5 cases.
    Chen JW; Chen DZ; Yang ZR
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):182-4. PubMed ID: 15908312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living donor liver transplantation and hepatitis C: lessons from the learning curve?
    Carrión JA; Forns X
    Liver Transpl; 2007 Jan; 13(1):18-20. PubMed ID: 17192905
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine A withdrawal during follow-up after pediatric liver transplantation.
    Scheenstra R; Torringa ML; Waalkens HJ; Middelveld EH; Peeters PM; Slooff MJ; Gouw AS; Verkade HJ; Bijleveld CM
    Liver Transpl; 2006 Feb; 12(2):240-6. PubMed ID: 16447209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adverse pharmacology of calcineurin inhibitors and their impact on hepatitis C recurrence after liver transplantation: implications for clinical practice.
    Garcia-Saenz-de-Sicilia M; Mukherjee S
    Expert Rev Clin Pharmacol; 2012 Sep; 5(5):587-93. PubMed ID: 23121280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus and transplantation.
    Durand F; Marcellin P
    Acta Gastroenterol Belg; 2000; 63(2):219-20. PubMed ID: 10925471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.